Moreover, CysLT1R overexpression has been observed in different types of cancers, including colorectal cancer, breast cancer, prostate cancer, urothelial transitional cell carcinoma and renal cell carcinoma [10,11,12,13,14,15,16,17]. Here, CYSLTR1 is linked to breast carcinoma.